Modifying PEST for Psoriatic Arthritis Screening

Clinical trial NCT06382051 · RECRUITING

Trial details

NCT number: NCT06382051
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Plaque Psoriasis Psoriatic Arthritis

Start date: 2025-01-23
Primary completion: 2026-08-28
Enrollment: 502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.